Andere Sprachen Iqvia Holdings Inc.

Aktien

A2JSPM

US46266C1053

IQV

Biotechnologie

Realtime-Estimate Cboe BZX Andere Börsenplätze 18:49:31 03.12.2024			% 5 Tage	% 1. Jan.
200,09 ^USD	-0,84 %		-0,64 %	-13,59 %

02.12.	IQVIA HOLDINGS INC. : Kaufen-Bewertung von Nephron Research	ZM
02.12.	IQVIA HOLDINGS INC. : Von Nephron Research zum Kaufen aufgerüstet	ZM

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Iqvia : UBS Global Healthcare Conference	06.11.
IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024	06.11.
Analyst recommendations: Amazon.com, Mastercard, Bristol-Myers Squibb Company, Uber Technologies, Regeneron Pharmaceuticals...	01.11.
Sector Update: Health Care Stocks Lower to Flat Premarket Thursday	31.10.
IQVIA Q3 Adjusted Earnings, Revenue Rise; Lowers Full-Year Revenue Outlook; Shares Fall	31.10.
IQVIA : Reports Third Quarter 2024 Results and Announces Investor Day Form 8 K	31.10.
IQVIA: Q3 Earnings Snapshot	31.10.
Earnings Flash (IQV) IQVIA HOLDINGS Posts Q3 Revenue $3.9B	31.10.
Earnings Flash (IQV) IQVIA HOLDINGS Posts Q3 EPS $2.84	31.10.
IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day	31.10.
Tranche Update on IQVIA Holdings Inc.'s Equity Buyback Plan announced on October 31, 2013.	31.10.
IQVIA Holdings Inc. Updates Earnings Guidance for the Full Year 2024	31.10.
IQVIA Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	31.10.
IQVIA Holdings Faces Turbulence Amid Large Pharma Reorganizations, Budget Cuts, RBC Says	29.10.
Emcure Pharmaceuticals Limited Announces Formation of Wholly-Owned Subsidiary, Emcutix Biopharmaceuticals Limited	28.10.
IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024	15.10.
Syneos Health Announces Chief Executive Officer Changes	09.10.
IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™	02.10.
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award	19.09.
IQVIA Applauded by Frost & Sullivan for Improving the Performance of QARA Professionals, Patient Safety, and Commercial Performance with Its AI Solutions	12.09.
Veeva Systems: leader in cloud solutions for the life sciences industry	06.09.
'Brighter Skies' Ahead for IQVIA As EPS Set to 'Reaccelerate', RBC Capital Says	04.09.
Signant Health Expands Availability of its eClinical Solutions by Joining IQVIA One Home for Sites Initiative	04.09.
Veeva Systems Inc.: leider in cloudoplossingen voor de biowetenschappen	04.09.
Veeva Systems: leader nelle soluzioni cloud per il settore delle scienze della vita	03.09.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Iqvia Holdings Inc.

Aktien

A2JSPM

US46266C1053

IQV

Biotechnologie

Andere Sprachen

Filter